Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $3.98
- Average 1Y price target
- $9.00+126.13%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF5
- Return on equity1
- Return on assets1
- Debt / equity1
- P/E1
- P/B2
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 3 | $10.00 |
| All time | 4 | $9.00 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 21, 2026 | Wedbush | downgrade | Outperform | Neutral |
| Apr 21, 2026 | TD Cowen | downgrade | Buy | Hold |
| Apr 21, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 21, 2026 | Chardan Capital | downgrade | Buy | Neutral |
| Mar 4, 2026 | Canaccord Genuity | maintain | Buy | Buy |
| Nov 12, 2025 | Chardan Capital | maintain | Buy | Buy |
| Aug 14, 2025 | Guggenheim | maintain | Buy | Buy |
| Aug 14, 2025 | Canaccord Genuity | maintain | Buy | Buy |
| Aug 13, 2025 | Wedbush | maintain | Outperform | Outperform |
| Jun 24, 2025 | Chardan Capital | maintain | Buy | Buy |
| Mar 4, 2025 | Chardan Capital | maintain | Buy | Buy |
| Nov 14, 2024 | Chardan Capital | maintain | Buy | Buy |
| Nov 14, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Sep 17, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| May 15, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Mar 5, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Nov 14, 2023 | Raymond James | maintain | Outperform | Outperform |
| Aug 8, 2023 | Chardan Capital | maintain | Buy | Buy |
| May 12, 2023 | Raymond James | maintain | Outperform | Outperform |
| Dec 15, 2022 | Chardan Capital | maintain | Buy | Buy |
| Nov 11, 2022 | Guggenheim | maintain | Buy | Buy |
| Nov 11, 2022 | Citigroup | maintain | Buy | Buy |
| Nov 8, 2022 | Canaccord Genuity | maintain | Buy | Buy |
| May 17, 2022 | Raymond James | maintain | Outperform | Outperform |
| May 17, 2022 | Citigroup | maintain | Buy | Buy |
| Mar 8, 2022 | JP Morgan | downgrade | Overweight | Neutral |
| Mar 4, 2022 | Raymond James | maintain | Outperform | Outperform |
| Jan 19, 2022 | Goldman Sachs | downgrade | Buy | Neutral |
| Jul 1, 2021 | Raymond James | maintain | Outperform | Outperform |
| Jun 15, 2021 | BTIG | maintain | Buy | Buy |
| Mar 8, 2021 | Chardan Capital | maintain | Buy | Buy |
| Mar 4, 2021 | Goldman Sachs | upgrade | Neutral | Buy |
| Feb 4, 2021 | Guggenheim | maintain | Buy | Buy |
| Jan 4, 2021 | JP Morgan | upgrade | Neutral | Overweight |
| Dec 11, 2020 | Citigroup | maintain | Neutral | Neutral |
| Aug 14, 2020 | JP Morgan | downgrade | Overweight | Neutral |
| Jun 25, 2020 | Goldman Sachs | downgrade | Buy | Neutral |
| May 11, 2020 | Chardan Capital | maintain | Buy | Buy |
| Mar 25, 2020 | Chardan Capital | maintain | Buy | Buy |
| Mar 24, 2020 | Goldman Sachs | maintain | Buy | Buy |